Back to search

United Kingdom· GB-APID-21930011000001100

Tresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pens

A insulin degludec product containing insulin degludec, registered in United Kingdom by Novo Nordisk Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC A10AE06

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTresiba FlexTouch 100units/ml solutio…ATCA10AE06REGISTER NO.GB-APID-2193001100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Insulin degludec is registered in 14 of 19 countries.

Countries holding a registration under ATC A10AE06 (insulin degludec), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Insulin degludec · ATC A10AE06

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Insulin degludec
Manufacturer
Novo Nordisk Ltd
Country
United Kingdom (GB)
ATC code
A10AE06
ATC class
Insulin degludec
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5017954001903
  • gtin
    5712249124786

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

431 interactions on record for insulin degludec.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Insulin degludec · interactions on record

431 records

  • 15 severe
  • 366 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin degludec in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin degludec products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Tresiba Flexpen, Tresiba Flextouch
  • Norway · Tresiba, Tresiba Flexpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9cb889b-2ab6-4200-ac80-70937d767f27
GET /v1/drugs/f9cb889b-2ab6-4200-ac80-70937d767f27?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "21930011000001100",
  "desc": "Tresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd)",
  "form": "Solution for injection",
  "vpid": "21939611000001101",
  "source": "dmd",
  "vtm_id": "776340008",
  "strength": "100 unit",
  "substance": "Insulin degludec",
  "ingredient": "Insulin degludec",
  "supplier_code": "2080301000001101"
}

See everything about insulin degludec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.